Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Beckman Coulter

Beckman Coulter

Beckman Coulter, Inc. was incorporated in Delaware in 1988. Beckman and Coulter combines two of the known brand names in laboratories. The Company adopted its current name in April 1998, changing from Beckman Instruments, Inc. to Beckman Coulter, Inc., to reflect the October 1997 acquisition of Coulter Corporation. The Company is a manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes. Spanning the biomedical testing continuum - from pioneering medical research and clinical trials to laboratory diagnostics and point-of-care testing - the Company's installed base of systems provides essential biomedical information to improve patient health and reduce the cost of care. The Company's inspiration is to improve patient health and reduce the cost of care with products that fall into two basic categories: Clinical Diagnostics and Life Science research instruments and tools. Clinical Diagnostics produces information physicians use to diagnose disease, make treatment decisions and monitor patients in hospitals and other critical care settings around the world. The clinical diagnostic customers include hospitals, physician's offices and reference laboratories. Central laboratories of mid- to large-size hospitals represent its main customer group. Life Science research instruments and tools are used by scientists to study complex biological problems including the causes of disease, identifying new therapies and testing new drugs. The Life Science customers include pharmaceutical and biotechnology companies, universities, medical schools and research institutions. The Company encounters competition from many domestic and international manufacturers, with many of these companies participating in one or more parts of each of its market segments. Most of the Company's products are distributed by its own marketing, service and sales organizations in major markets. The Company relies on trademarks, copyrights, trade secrets, know-how and confidentiality agreements to develop, maintain and strengthen our competitive position. Beckman Coulter's products and operations are subject to a number of federal, state, local and foreign laws and regulations. All of its Clinical Diagnostics products and some of its Life Science products are classified as 'medical devices' under the United States Food, Drug and Cosmetic Act.

Formerly Known As
Arnold O. Beckman, SmithKline Beckman, National Technical Laboratories, Beckman Instruments
Ownership Status
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Diagnostic Equipment
Parent Company
Former Stock Listing
Primary Office
  • 250 South Kraemer Boulevard
  • Brea, CA 92821
  • United States

+1 (714) 000-0000

Beckman Coulter Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
Debt Status

This information is reserved for PitchBook Platform users. To explore Beckman Coulter‘s full profile, request access.

Request full access to PitchBook

Beckman Coulter Competitors (19)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bio-Rad Laboratories Corporation Hercules, CA 0000
00000000 000000000 Corporation Cincinnati, OH 000
00000000000 Corporation Waltham, MA 00000
000000 00000000000 Failed Transaction (M&A) Lake Forest, IL 000000&0
00 0000000000 Corporation Chicago, IL 00000
To view this company’s complete list of competitors, request access »

Beckman Coulter Investments & Acquisitions (22)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 30-Jan-2019 000000000000000000 Other Healthcare Technology Systems 00000000 00000
0000000 (00000000 31-Jan-2015 000000000000000000 Drug Discovery 0000 000000000
00000000 000000000 23-Apr-2014 000000000000000000 Diagnostic Equipment 00000000 000000000
0000000 0000000000 23-Apr-2014 000000000000000000 Diagnostic Equipment 00000000 000000000
ReaMetrix (flow cytometry business assets) 08-Aug-2013 Merger/Acquisition Other Healthcare Technology Systems 00000 000000 00
To view this company’s complete investment and acquisition history, request access »

Beckman Coulter Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000000 01-May-2011 00000 00000 00 Completed
  • 2 buyers
To view this company’s complete exits history, request access »

Beckman Coulter Subsidiaries (5)

Company Name Industry Location Founded
Labcyte Other Healthcare Technology Systems San Jose, CA 2000
0000000 0000000 00 Corporate Pension Brea, CA 0000
0000000 Specialty Chemicals Southfield, MI 0000
0000 0000000000000 Diagnostic Equipment Los Angeles, CA 0000
0000000 0000000 00 Corporate Pension Galway, Ireland
To view this company’s complete subsidiary history, request access »

Beckman Coulter Executive Team (25)

Name Title Board
Jonathan Pratt President
Knud Mueller Senior Vice President & Chief Financial Officer
Yong Chen Chief Technology Officer
Mario Koksch MD Vice President & General Manager of Flow Cytometry BU
Robert Raynor Ph.D Director, Corporate Business Develoment

10 Former Executives

You’re viewing 5 of 25 executives. Get the full list »